Forbion Growth Opportunities Fund I Cooperatief U.A.
CIK: 0001911047
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
enGene Holdings Inc.
Discretionary Trading P&L
Holdings
Transaction History (14 total)
- Oct 30, 2024ENGN
enGene Holdings Inc.
Purchase(P)Direct561.8K shares at avg. $8.90$5.0M - Oct 8, 2024ENGN
enGene Holdings Inc.
Purchase(P)Direct800 shares at avg. $6.60$5K - Oct 7, 2024ENGN
enGene Holdings Inc.
Purchase(P)Direct11.8K shares at avg. $6.55$78K - Oct 4, 2024ENGN
enGene Holdings Inc.
Purchase(P)Direct6K shares at avg. $6.54$39K - Oct 3, 2024ENGN
enGene Holdings Inc.
Purchase(P)Direct5.8K shares at avg. $6.48$37K - Oct 2, 2024ENGN
enGene Holdings Inc.
Purchase(P)Direct10.2K shares at avg. $6.37$65K - Oct 1, 2024ENGN
enGene Holdings Inc.
Purchase(P)Direct35.3K shares at avg. $6.44$227K - Sep 30, 2024ENGN
enGene Holdings Inc.
Purchase(P)Direct341.3K shares at avg. $6.34$2.2M - Sep 27, 2024ENGN
enGene Holdings Inc.
Purchase(P)Direct3.2K shares at avg. $6.38$21K - Sep 27, 2024ENGN
enGene Holdings Inc.
Purchase(P)Direct38.4K shares at avg. $5.94$228K - Dec 29, 2023ENGN
enGene Holdings Inc.
Purchase(P)Direct9.6K shares at avg. $9.09$87K - Dec 29, 2023ENGN
enGene Holdings Inc.
Purchase(P)Direct400 shares at avg. $8.30$3K - Dec 28, 2023ENGN
enGene Holdings Inc.
Purchase(P)Direct5.1K shares at avg. $7.69$39K - Dec 27, 2023ENGN
enGene Holdings Inc.
Purchase(P)Direct2.8K shares at avg. $7.17$20K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Oct 30, 2024 | ENGN enGene Holdings Inc. | Purchase(P) | 561,797 | $8.90 | $4,999,993 | Direct |
| Oct 8, 2024 | ENGN enGene Holdings Inc. | Purchase(P) | 800 | $6.60 | $5,278 | Direct |
| Oct 7, 2024 | ENGN enGene Holdings Inc. | Purchase(P) | 11,844 | $6.55 | $77,531 | Direct |
| Oct 4, 2024 | ENGN enGene Holdings Inc. | Purchase(P) | 5,997 | $6.54 | $39,242 | Direct |
| Oct 3, 2024 | ENGN enGene Holdings Inc. | Purchase(P) | 5,769 | $6.48 | $37,397 | Direct |
| Oct 2, 2024 | ENGN enGene Holdings Inc. | Purchase(P) | 10,153 | $6.37 | $64,697 | Direct |
| Oct 1, 2024 | ENGN enGene Holdings Inc. | Purchase(P) | 35,279 | $6.44 | $227,158 | Direct |
| Sep 30, 2024 | ENGN enGene Holdings Inc. | Purchase(P) | 341,332 | $6.34 | $2,163,362 | Direct |
| Sep 27, 2024 | ENGN enGene Holdings Inc. | Purchase(P) | 3,243 | $6.38 | $20,688 | Direct |
| Sep 27, 2024 | ENGN enGene Holdings Inc. | Purchase(P) | 38,396 | $5.94 | $228,011 | Direct |
| Dec 29, 2023 | ENGN enGene Holdings Inc. | Purchase(P) | 9,620 | $9.09 | $87,451 | Direct |
| Dec 29, 2023 | ENGN enGene Holdings Inc. | Purchase(P) | 400 | $8.30 | $3,320 | Direct |
| Dec 28, 2023 | ENGN enGene Holdings Inc. | Purchase(P) | 5,050 | $7.69 | $38,827 | Direct |
| Dec 27, 2023 | ENGN enGene Holdings Inc. | Purchase(P) | 2,750 | $7.17 | $19,711 | Direct |
1-14 of 14 transactions
About Forbion Growth Opportunities Fund I Cooperatief U.A.
Forbion Growth Opportunities Fund I Cooperatief U.A. (SEC CIK 0001911047) files insider reports with the SEC as 10% Owner of enGene Holdings Inc. (ENGN).
Signal8 holds 2 ownership filings by Forbion Growth Opportunities Fund I Cooperatief U.A., all Form 4s, filed between Oct 18, 2024 and Nov 1, 2024. Those filings report 14 transactions, from Dec 27, 2023 to Oct 30, 2024. Signal8's Form 4 history starts in Sep 2024.
The business address on Forbion Growth Opportunities Fund I Cooperatief U.A.'s filings is in NAARDEN, P7.
Recent filings by Forbion Growth Opportunities Fund I Cooperatief U.A.
- Oct 30, 2024: Open-market purchase of ENGN shares (Form 4, code P).
- Oct 8, 2024: Open-market purchase of ENGN shares (Form 4, code P).
- Oct 7, 2024: Open-market purchase of ENGN shares (Form 4, code P).
- Oct 4, 2024: Open-market purchase of ENGN shares (Form 4, code P).
- Oct 3, 2024: Open-market purchase of ENGN shares (Form 4, code P).
Other insiders filing for enGene Holdings Inc. (ENGN)
- Grossman William, Interim Chief Medical Officer
- Chinoporos Constantine, Interim Chief Business Officer
- Richton Kathleen P., SVP, Finance and Treasurer
- Astley-Sparke Philip, Director
- BRUNK GERALD A, Director
- Glickman Richard M, Director